Exploring the Opportunities and Challenges in Repurposing a Master Dossier
It is known that developing an innovative healthcare product from bench to market is a very expensive and complex effort, as the pharmaceutical industry is highly regulated to protect the consumer....
View ArticleThe Total IDMP Effort – an insight into the data volume of an ISO IDMP...
It has, since 2012, been a well-established fact that pharmaceutical companies which have medicinal products or are conducting clinical trials in the European Union (EU) will have to adhere to the ISO...
View ArticleWhy Agility Holds the Key to Transformation in Life Sciences
The priority that will unite all life sciences companies in 2016 is the pursuit of greater agility. As long as organisations keep taking a short-term view, investing in standalone information...
View ArticleHow to Protect Your IP Rights Abroad
Many life sciences companies which protect their inventions, brands or product designs through patents, trademarks or registered designs in their home country, do not realise that this does not give...
View Article